Moreover, because cell surface clustering of a variety of receptors, including EGFR, has been shown to augment receptor function[5,17-19], we hypothesized that α6β4 integrin-induced EGFR clustering might augment particular tumor cell responses to EGF. The gene discussed is EGFR; the disease is neoplasm.